Non-proliferative Diabetic Retinopathy
📧 Sign up to get email alerts when something new happens for Non-proliferative Diabetic Retinopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Safety and Efficacy of Faricimab in Patients With NPDR [Phase 2]
Phase 2 clinical trial update assessing Faricimab in non-proliferative diabetic retinopathy, focusing on safety and efficacy outcomes.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of the axitinib implant (OTX-TKI) for non-proliferative diabetic retinopathy,…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation [Phase 2]
Phase 2 single-site pilot trial of QLS-111 ophthalmic solution evaluating posterior perfusion and vessel dilation in non-proliferative diabe…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Study of INV-102 Ophthalmic Solution in Adults With Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy [Phase 2]
A Phase 2 trial evaluating INV-102 Ophthalmic Solution in adults with diabetic macular edema associated with non-proliferative diabetic reti…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Characterization of Retinal Disease Progression in Eyes With Non Proliferative Diabetic Retinopathy in Diabetes Type 2 Using Non-invasive Procedures (CHART)
This completed clinical trial update characterizes the progression of non-proliferative diabetic retinopathy in adults with type 2 diabetes …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion [Phase 2]
Clinical trial update for a Phase 2 safety and proof-of-concept study of ANXV (Annexin A5) in patients with non-proliferative diabetic retin…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: To Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy in Patients With NPDR [Phase 4]
Phase 4 clinical trial comparing combination therapy with B55R1 and B55R2 versus B55R1 alone in non-proliferative diabetic retinopathy has c…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: A Preliminary Exploratory Clinical Trial to Evaluate the Efficacy of NPDR-01 Eye Drops in the Treatment of Non-Proliferative Diabetic Retinopathy [EARLY_Phase 1]
This is an early Phase 1 exploratory clinical trial to evaluate the efficacy of NPDR-01 Eye Drops in treating non-proliferative diabetic ret…
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy [Phase 3]
This clinical trial update outlines a Phase 3 study evaluating TNTL for non-proliferative diabetic retinopathy. Recruitment is currently ong…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy [NA]
A clinical trial evaluating remote ischemic conditioning for non-proliferative diabetic retinopathy is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Efficacy and Safety of Conbercept for Diabetic Macular Edema Combined With Severe Non-proliferative Diabetic Retinopathy [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of Conbercept for diabetic macular edema in patients with severe non-prolif…
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Lowering Events in Non-proliferative Retinopathy in Scotland [Phase 4]
Phase 4 clinical trial in Scotland assessing strategies to reduce events in non-proliferative diabetic retinopathy has completed and posted …
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Intravitreal and Intracameral DEX in NPDR [Phase 3]
A Phase 3 clinical trial evaluating intravitreal and intracameral dexamethasone for non-proliferative diabetic retinopathy is currently enro…
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: A Study to Learn How Safe BAY3283142 is When Taken as a Single Dose or as Multiple Doses in Healthy Chinese Participants [Phase 1]
Phase 1 safety study of BAY3283142 in healthy Chinese participants to assess single-dose and multiple-dose safety, sponsored by Bayer.
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR) [Phase 3]
A Phase 3 trial evaluating intravitreal KSI-301 for non-proliferative diabetic retinopathy was terminated, with results posted.
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of OPL-0401 in diabetic retinopathy; the study is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment [Phase 4]
A Phase 4 trial update on PASCAL laser treatment for diabetic retinopathy, detailing changes in electroretinogram and contrast sensitivity; …
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy [Phase 2]
Phase 2 clinical trial update for Tangningtongluo Tablet evaluating treatment for non-proliferative diabetic retinopathy in patients with ty…
-
CLINICAL_TRIALS trial_result · 2023-02-27Clinical Trial Update: Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy [Phase 2]
Phase 2 trial assessing APX3330 for safety and efficacy in diabetic retinopathy and diabetic macular edema has completed.
-
CLINICAL_TRIALS trial_result · 2022-07-21Clinical Trial Update: Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic Retinopathy [Phase 4]
Phase 4 trial evaluating efficacy and safety of Entelon 50mg in patients with non-proliferative diabetic retinopathy.
-
CLINICAL_TRIALS trial_result · 2022-05-23Clinical Trial Update: Phacoemulsification Combined With Intravitreal Injection of Ranibizumab Prevent Postoperative Capillary Non-perfusion Zone Progress in Non-proliferative Diabetic Retinopathy [Phase 4]
Phase 4 trial updating outcomes of phacoemulsification with intravitreal ranibizumab to prevent progression of capillary non-perfusion in no…
-
CLINICAL_TRIALS research · 2021-12-03Clinical Trial Update: Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema [Phase 4]
Phase 4 trial update examining bevacizumab and peripheral retinal changes on wide-field angiography in diabetic retinopathy and diabetic mac…
-
CLINICAL_TRIALS trial_result · 2020-08-13Clinical Trial Update: Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy [Phase 2, Phase 3]
A clinical trial update for intravitreal bevacizumab in nonproliferative diabetic retinopathy across Phase 2 and Phase 3 stages.
-
CLINICAL_TRIALS trial_result · 2017-12-15Clinical Trial Update: A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy [Phase 2]
Phase 2 clinical trial evaluating Luminate in inducing posterior vitreous detachment for non-proliferative diabetic retinopathy has complete…
-
CLINICAL_TRIALS research · 2017-10-13Clinical Trial Update: Safety and Effectiveness Study of 532nm Laser Subthreshold Panretinal Photocoagulation for Severe NPDR [NA]
This entry describes an ongoing clinical trial evaluating the safety and effectiveness of a 532 nm laser subthreshold panretinal photocoagul…